Mark John Austin - 23 Apr 2024 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Reporting relationship: VP Finance/Prin Fin&Acct Offic
Issuer ticker: CATX
Reported as of: 23 Apr 2024
Net transaction value: +$10,800
SEC form: 4
Accepted by SEC: 24 Apr 2024, 16:35:11 UTC
Prior SEC filing: 14 Jun 2023
Next SEC filing: 19 Jul 2024
Source filing: View source filing
Reporting owner signature: /s/ Mark Austin

Key filing fact

Mark John Austin filed Form 4 for Perspective Therapeutics, Inc. (CATX) on 24 Apr 2024.

Key facts

This page summarizes Mark John Austin's Form 4 filing for Perspective Therapeutics, Inc. (CATX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 24 Apr 2024, 16:35.

Change

Previous filing in this sequence was filed on 14 Jun 2023.
Current net transaction value: +$10,800.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CATX transaction

Common stock

Options Exercise

Transaction value: $10,800
Shares: +30,000
Change %: +56%
Price: $0.3600
Shares after: 84,030
Date: 23 Apr 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CATX transaction Derivative

Stock option (right to buy)

Options Exercise

Transaction value: $0
Shares: -30,000
Change %: -20%
Price: $0.000000
Shares after: 120,000
Date: 23 Apr 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 150,000
Exercise price: $0.3600
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Stock Option is fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .